Excellence in Quality & Outcomes
By The Numbers
Behind every number is a patient, which is why we strive to deliver the best possible stroke care for our community. Here is how AtlantiCare’s Comprehensive Stroke Center performed in 2022:
Total Number of Stroke patients treated at AtlantiCare:
- Ischemic Stroke (Blood Clot in the Brain): 633
- Hemorrhagic Stroke (Bleeding in the Brain): 131
Our experienced team diagnoses, prevents and treats stroke with clot-busting medications and advanced minimally invasive technology. We continually focus on decreasing time to treatment for stroke patients, as improving access to emergency medical treatments of stroke improves patient outcomes and saves viable brain tissue.
- Number of Patients treated with IV thrombolytics (clot-busting medication): 93
- Number of Patients treated with mechanical thrombectomy (blood clot removal): 74
- Number of aneurysms treated at AtlantiCare: 22
- Percent of patients that AtlantiCare provides the highest quality of care by meeting all Stroke Quality Measures: 98.3%
The table below shows infection, stroke, and death rates for common neurosurgical procedures performed at AtlantiCare. The first three rows are procedures that look at and/or treat the vessels supplying the brain in the head and neck. The last row is a procedure that can assist with drainage of excess fluid around the brain.
2021 Surgical Complication Rates
Comprehensive Stroke Center Requirements
ARMC City Campus 2021
Stroke or Death within 24 hours following Diagnostic Cerebral Angiogram
Less than 1%
0%
Comprehensive Stroke Center Requirements: Less than 1%
ARMC City Campus 2020: 0.56%
Stroke or Death within 30 Days following Carotid Endarterectomy or Stenting for treatment of asymptomatic stenosis (narrowing of blood vessel)
Less than 3%
1.5%
Comprehensive Stroke Center Requirements: Less than 3%
ARMC City Campus 2020: 0%
Stroke or Death within 30 Days following Carotid Endarterectomy or Stenting for treatment of symptomatic stenosis (narrowing of blood vessel)
Less than 6%
0%
Comprehensive Stroke Center Requirements: Less than 6%
ARMC City Campus 2020: 0%
Infections following placement of External Ventricular Drainage Device
Track & Trend
0%
Comprehensive Stroke Center Requirements: Track & Trend
ARMC City Campus 2020: 0%
The table below shows symptomatic bleeding rates for patients who receive emergent treatment for a stroke caused by a blood clot. Each treatment type, thrombolytics (clot busting medication) and mechanical thrombectomy (clot removal surgery) has a risk of bleeding associated with the treatment. However, this risk can be minimized through proper selection criteria, technique, and monitoring.